James Collins, Broad Institute via Youtube
A space odyssey for new antibiotics: MIT's machine learning approach
Drug development is complex, expensive and comes with lousy odds of success — but in most cases, if you make it across the finish line brandishing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
